KTTAW Analyst Ratings 2026
Pasithea Therapeutics Corp. - Wall Street recommendations & price targets
Consensus Rating
N/A
Current Price
$0.01
Get Complete KTTAW Analysis
AI insights, DCF valuation, and institutional ownership
View Full AnalysisFrequently Asked Questions
What is the analyst rating for KTTAW?
Analyst rating data for KTTAW is being updated. Check back for the latest Wall Street recommendations.
What is the KTTAW price target?
Price target data for KTTAW is being updated.
Is KTTAW a buy according to analysts?
Check the latest analyst recommendations for KTTAW.
How many analysts cover KTTAW?
Analyst coverage information for KTTAW is being updated.